<?xml version="1.0" encoding="UTF-8" standalone="yes"?><rss version="2.0"><channel><title>Brineura RSS feed</title><ttl>1440</ttl><copyright>Copyright: (C) European Medicines Agency</copyright><language>en-gb</language><lastBuildDate>Thu, 13 Jul 2017 18:48:51 +0100</lastBuildDate><link>http://www.ema.europa.eu</link><description>Brineura RSS feed</description><item><title>Human medicines European Public Assessment Report (EPAR): Brineura, cerliponase alfa, Revision: 0, Authorised</title><guid isPermaLink="true">http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004065/human_med_002111.jsp&amp;mid=WC0b01ac058001d124</guid><link>http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004065/human_med_002111.jsp&amp;mid=WC0b01ac058001d124</link><description><![CDATA[]]></description><pubDate>Thu, 22 Jun 2017 00:00:00 +0100</pubDate></item><item><title>Brineura : EPAR - All Authorised presentations</title><guid isPermaLink="true">http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_All_Authorised_presentations/human/004065/WC500229799.pdf</guid><link>http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_All_Authorised_presentations/human/004065/WC500229799.pdf</link><description><![CDATA[]]></description><pubDate>Thu, 22 Jun 2017 00:00:00 +0100</pubDate></item><item><title>Brineura : EPAR - Product Information</title><guid isPermaLink="true">http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004065/WC500229798.pdf</guid><link>http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004065/WC500229798.pdf</link><description><![CDATA[]]></description><pubDate>Thu, 22 Jun 2017 00:00:00 +0100</pubDate></item><item><title>Brineura : EPAR - Summary for the public</title><guid isPermaLink="true">http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/004065/WC500229801.pdf</guid><link>http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/004065/WC500229801.pdf</link><description><![CDATA[]]></description><pubDate>Thu, 22 Jun 2017 00:00:00 +0100</pubDate></item><item><title>Brineura : EPAR - Public assessment report</title><guid isPermaLink="true">http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004065/WC500229800.pdf</guid><link>http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004065/WC500229800.pdf</link><description><![CDATA[]]></description><pubDate>Thu, 22 Jun 2017 00:00:00 +0100</pubDate></item><item><title>CHMP summary of positive opinion for Brineura</title><guid isPermaLink="true">http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/004065/WC500226157.pdf</guid><link>http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/004065/WC500226157.pdf</link><description><![CDATA[]]></description><pubDate>Fri, 21 Apr 2017 00:00:00 +0100</pubDate></item><item><title>News and Press Releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 April 2017</title><guid isPermaLink="true">http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/04/news_detail_002732.jsp&amp;mid=WC0b01ac058004d5c1</guid><link>http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/04/news_detail_002732.jsp&amp;mid=WC0b01ac058004d5c1</link><description><![CDATA[Eleven medicines recommended for approval, including four orphans]]></description><pubDate>Fri, 21 Apr 2017 00:00:00 +0100</pubDate></item><item><title>News and Press Releases: New medicine for rare neurodegenerative disorder in children</title><guid isPermaLink="true">http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/04/news_detail_002734.jsp&amp;mid=WC0b01ac058004d5c1</guid><link>http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/04/news_detail_002734.jsp&amp;mid=WC0b01ac058004d5c1</link><description><![CDATA[Brineura reviewed under accelerated assessment]]></description><pubDate>Fri, 21 Apr 2017 00:00:00 +0100</pubDate></item></channel></rss>